A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Cross, M.D.
Washington University, Saint Louis, MO
Principal Investigator - Anthony Reder, M.D.
University of Chicago
Principal Investigator - Barbara Giesser, M.D.
University of California, Los Angeles (UCLA), Los Angeles, CA
Principal Investigator - Corey Ford, M.D.
University of New Mexico, Albuquerque
Principal Investigator - Dean Wingerchuk, M.D.
Mayo Clinic
Principal Investigator - Dina Jacobs, M.D.
University of Pennsylvania
Principal Investigator - Elliot Frohman, M.D.
University of Texas, Southwestern, Dallas, TX
Principal Investigator - Gareth Parry, M.D.
University of Minnesota
Principal Investigator - John Corboy, M.D.
University of Colorado, Denver
Principal Investigator - John Ratchford, M.D.
Johns Hopkins, Baltimore, MD
Principal Investigator - John Rose, M.D.
Western Institute for Biomedical Research, Salt Lake City, UT
Principal Investigator - Lloyd Kasper, M.D.
Dartmouth University, Lebanon, NH
Principal Investigator - Michael Racke, M.D.
Ohio State University
Principal Investigator - Rhonda Voskuhl, M.D.
University of California, Los Angeles (UCLA), Los Angeles, CA
Study Director - Sharon Lynch, M.D.
University of Kansas
Principal Investigator - Suhayl Dhib-Jalbut, M.D.
Robert Wood Johnson Medical School, UMDNJ, New Brunswick, NJ
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Montreal Neurological Institute
Montreal, Canada
- Mayo Clinic
Scottsdale, Arizona, United States
- University of California, Los Angeles
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas
Kansas City, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Dartmouth Medical School
Lebanon, New Hampshire, United States
- Umdnj-Robert Wood Johnson Medical Center
New Brunswick, New Jersey, United States
- University of New Mexico
Albuquerque, New Mexico, United States
- Ohio State University
Columbus, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Western Institute for Biomedical Research
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2007
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 16 Jun 2016
- Registered enrollment
- 158
- Registry id
- NCT00451204
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.